Jeanne Mell
Vice President Corporate Communications
OraSure Technologies, Inc.
OraSure Technologies, Inc.
Jeanne gave us excellent insight into how OraSure develops and delivers game-changing, innovative sampling tools, services and diagnostics designed to help its customers and partners get the best answers to their most critical questions, more easily and with more illuminating insights. OraSure is leveraging its global leadership in infectious disease diagnostics to develop tests for COVID-19. Founded in 1987 as Solar Care Technologies, an incubator project at the Ben Franklin Partnership now OraSure Technologies, it now has over 600+ employees with offices in the US, Canada and Belgium with Products registered in 89 countries.
COVID-19 Activities have focused on Sample Collection Devices for Molecular Testing; Rapid Antigen Self-Test and Oral Fluid Antibody ELISA.
Significant Benefits:
Convenient, pain-free self-collection
Increased access to testing
Less burden on healthcare systems
Minimized exposuire risks to healthcare workers
Conserve much-needed PPE
OraSure has been a Trailblazer in HIV OraQuick Self-Testing - First and only rapid HIV in-home test approved by FDA; First and only WHO-prequalified rapid oral HIV self-test
21% of the 38 million people with HIV do not know their status
Safe, accurate, convenient point-of-care and in-home HOIV tests key to identifying HIV positive patients and linking them to care
Millions of OraQuick HIV tests have been sold around the world
Manufactured in Bethlehem
